Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer
Joy C. Yang, Pengfei Xu, Shu Ning, Logan J. Wasielewski, Hans Adomat, Sung Hee Hwang, Christophe Morisseau, Martin Gleave, Eva Corey, Allen C. Gao, Primo N. Lara, Christopher P. Evans, Bruce D. Hammock, Chengfei Liu
Topics & Concepts
EnzalutamideProstate cancerAndrogen receptorCancer researchBiologyCancerAndrogenAndrogen deprivation therapyInternal medicineEndocrinologyMedicineHormoneProstate Cancer Treatment and ResearchAldose Reductase and TaurineCancer-related gene regulation